Azar Defends Drug Pricing Plan’s Lack Of Importation, Direct Negotiation

May 16, 2018
HHS Secretary Alex Azar is explaining why the president’s newly released drug pricing plan doesn’t deliver on two of President Donald Trump’s campaign promises: direct drug price negotiation in Medicare and allowing importation of cheaper drugs from Canada. Azar argued that both proposals were left out because they don’t work, and while he dismissed importation outright, he argued that Trump’s plan will actually increase price negotiation in Medicare, just not the way both Democrats and Trump had pushed. “You’ve probably...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.